scholarly journals Disparities of birth cohort effects on pancreatic cancer incidence between the United States and urban China

ESMO Open ◽  
2021 ◽  
Vol 6 (5) ◽  
pp. 100240
Author(s):  
S. Yang ◽  
K.W. Yeoh ◽  
M.C.-S. Wong ◽  
O.W.-K. Mang ◽  
L.A. Tse
Circulation ◽  
2019 ◽  
Vol 139 (Suppl_1) ◽  
Author(s):  
Thanh-Huyen T Vu ◽  
Donald Lloyd-Jones ◽  
Mercedes R Carnethon ◽  
John T Wilkins ◽  
Hy Tran ◽  
...  

2019 ◽  
Vol 37 (18) ◽  
pp. 1538-1546 ◽  
Author(s):  
Joseph E. Tota ◽  
Ana F. Best ◽  
Zachary S. Zumsteg ◽  
Maura L. Gillison ◽  
Philip S. Rosenberg ◽  
...  

PURPOSE Human papillomavirus–positive oropharynx cancer incidence has increased rapidly in cohorts of US white men born during the 1930s to 1950s. It is unknown how the trajectory of the oropharynx cancer epidemic may be changing in the United States. METHODS Using US cancer registry information, we investigated whether increases in oropharynx cancer have continued into recent birth cohorts and forecasted the future burden across age, sex, and race/ethnicity subgroups. Log-linear Joinpoint regression and age-period-cohort models were used to evaluate incidence trends during 1992 to 2015 and projections through 2029. RESULTS Among white men, oropharynx cancer incidence increased rapidly in individuals born during 1939 to 1955 (5.3% per 2-year birth cohort; 95% CI, 4.8% to 5.7%), but this rate of increase significantly moderated in individuals born during 1955 to 1969 (1.7% per 2-year birth cohort; 95% CI, 1.0% to 2.4%). Should these birth-cohort trends continue, from 2016 to 2029 we forecast that incidence will increase dramatically in older white men 65 to 74 years of age (from 40.7 to 71.2 per 100,000) and 75 to 84 years of age (from 25.7 to 50.1 per 100,000), moderately in white men 55 to 64 years of age (from 40.3 to 52.0 per 100,000), and remain stable in white men 45 to 54 years of age (approximately 18 per 100,000). Accounting for population growth, we project an increase in annual number of cases in the United States from 20,124 (95% CI, 19,779 to 20,469) in 2016 to 30,629 (95% CI, 29,413 to 31,845) in 2029, primarily driven by older individuals (age ≥ 65 years; from 7,976 [95% CI, 7,782 to 8,172] to 18,072 [95% CI, 17,271 to 18,895]) and white men (from 14,453 [95% CI, 14,142 to 14,764] to 22,241 [95% CI, 21,119 to 23,364]). CONCLUSION The exponential increase in oropharynx cancer incidence in young white US men has ebbed, and modest increases are occurring/anticipated in cohorts born after 1955. Continued strong increases in incidence in cohorts born before 1955, and an approximate 50% increase in size of the US population age 65 years or older through 2029, portend a substantial shift in burden to elderly white men.


2020 ◽  
Vol 18 (1) ◽  
pp. 171-178.e10 ◽  
Author(s):  
Anna Tavakkoli ◽  
Amit G. Singal ◽  
Akbar K. Waljee ◽  
B. Joseph Elmunzer ◽  
Sandi L. Pruitt ◽  
...  

Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 4203-4203
Author(s):  
Philip S Rosenberg ◽  
William F. Anderson

Abstract 4203 BACKGROUND: Leukemia (all types) is a common cancer in the United States (US) with 44,600 new cases expected in 2011. There are currently only a few established risk factors for any major type. If leukemia risks are substantially modulated by known or unknown environmental and lifestyle exposures, then incidence rates in the population should vary significantly by birth cohort. However, prior studies have not examined birth cohort effects using contemporary data and methods. METHODS: We used nationally representative data from the National Cancer Institute's Surveillance, Epidemiology and End Results Program for 1992 – 2008 (68,481 leukemias and 6.6×108 person-years of follow-up). For each major type in male and female pediatric (ages 0 – 17) and adult (ages 18 – 85) populations, we estimated the average annual percentage change in incidence attributable to calendar period and/or birth cohort (net drift), and the significance of unique (non-linear) birth cohort effects, using age-period-cohort statistical models and Poisson regression. RESULTS: In adults, birth cohort effects for AML were significant in men (P = 0.002) and borderline significant in women (P = 0.053). Compared to men born during 1947 – 1951, men born in the 1920s–1930s were 1.4-fold more likely to develop AML; AML rates were stable in men born after 1951. Birth cohort patterns for AML were qualitatively similar in women compared to men. For CLL, birth cohort effects were highly significant in men (P=5.7×10−6), peaking among men born circa 1939 and falling by 38% among men born circa 1963. In contrast, birth cohort effects for CLL were almost completely absent in women. For CML, incidence declined steadily by 1.3%/year among men (P = 0.0003) and by 1.5%/year among women (P = 0.0008). For ALL, incidence increased steadily by 2.0%/year among women (P = 0.001); birth cohort patterns were similar in men but not statistically significant (P = 0.36). In the pediatric population, AML rates were stable over time. In contrast, ALL rates increased by 1.4%/year among males (P = 0.001) and by 1.1%/year among females (P=0.04). CONCLUSIONS: In the US, leukemia risks increase or decrease substantially by birth cohort for each major leukemia type except adult female CLL and pediatric AML, on the order of 1–2%/year or 20–40% per generation. These results are consistent with the hypothesis that leukemia risks are substantially affected by known (i.e. smoking, certain chemicals) or suspected (i.e. obesity) environmental and lifestyle exposures, a number of which are potentially modifiable. Disclosures: No relevant conflicts of interest to declare.


2019 ◽  
Vol 156 (6) ◽  
pp. S-820
Author(s):  
Anna Tavakkoli ◽  
Amit G. Singal ◽  
Akbar K. Waljee ◽  
B. Joseph Elmunzer ◽  
Sandi Pruitt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document